The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injections of the missing FVIII often lead to the formation of inhibitory antibodies. Patients who develop high levels of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Yatuv, Rivka, Robinson, Micah, Dayan-Tarshish, Inbal, Baru, Moshe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2010
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2939703/
https://ncbi.nlm.nih.gov/pubmed/20856833
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller